期刊
ANNALS OF THE RHEUMATIC DISEASES
卷 69, 期 -, 页码 43-47出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/ard.2009.120113
关键词
-
类别
资金
- Arthritis Research Campaign (UK)
- Wellcome Trust
- Medical Research Council
- Medical Research Council [G0601422, G0801198] Funding Source: researchfish
- MRC [G0801198, G0601422] Funding Source: UKRI
Interleukin 33 (IL33) is a recently described member of the IL1 superfamily of cytokines. Originally defined on the basis of T-cell subset differentiation, IL33 is now recognised to mediate a wider role in regulating components of the innate immune response also, particularly via mast cell activation. In this paper the basic biology of IL33 is described together with that of its cognate receptor, ST2L, and the existing knowledge base for its potential role in mediating human pathology across a range of diseases is defined.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据